Kojin Therapeutics
Signal active
Organization
Contact Information
Overview
Founded by Stuart Schreiber, Benjamin Cravatt, Stephanie Dougan, and Vasanthi Viswanathan, Kojin is accelerating a drug discovery platform that connects complex cell states to known biochemical processes such as ferroptosis, or iron-dependent cell death, and enables the development of selective therapies for a broad range of hard-to-treat diseases.
The company’s investors include Polaris Partners, Newpath Partners, Cathay Health, Leaps by Bayer, AbbVie Inc., Eventide Asset Management, Alexandria, and the Dana-Farber Cancer Institute venture firm, Binney Street Capital.
About
Industries
Biotechnology, Life Science, Health Care, Medical, Biopharma
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Kojin Therapeutics headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care, Medical, Biopharma sector. The company focuses on Biotechnology and has secured $1.2B in funding across 20 round(s). With a team of 11-50 employees, Kojin Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Kojin Therapeutics, raised $60.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
8
Lead Investors
0
Total Funding Amount
$60.0M
Details
1
Kojin Therapeutics has raised a total of $60.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 60.0M |
Investors
Kojin Therapeutics is funded by 14 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Kojin Therapeutics | - | FUNDING ROUND - Kojin Therapeutics | 60.0M |
| Cathay Capital | - | FUNDING ROUND - Cathay Capital | 60.0M |
| Kojin Therapeutics | - | FUNDING ROUND - Kojin Therapeutics | 60.0M |
| Binney Street Capital | - | FUNDING ROUND - Binney Street Capital | 60.0M |
Recent Activity
There is no recent news or activity for this profile.